XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
At The Market Sales Agreement [Member]
Common Stock [Member]
Common Stock [Member]
At The Market Sales Agreement [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
At The Market Sales Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023 $ 82,547   $ 68   $ 321,642   $ (29) $ (239,134)
Beginning Balance (in shares) at Dec. 31, 2023     68,283,699          
Stock-based compensation 2,671       2,671      
Issuance of common stock from exercise of stock options 381       381      
Issuance of common stock from exercise of stock options (in shares)     243,254          
Issuance of common stock, net of commissions and allocated fees, less issuance costs   $ 9,664   $ 3   $ 9,661    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)       3,086,729        
Issuance of common stock from Employee Stock Purchase Plan 34       34      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     30,675          
Issuance of common stock from pre-funded warrant exercise     $ 4   (4)      
Issuance of common stock from pre-funded warrant exercise (in shares)     3,810,018          
Unrealized gains (losses) on available-for-sale marketable securities 168           168  
Net loss (36,496)             (36,496)
Ending Balance at Sep. 30, 2024 58,969   $ 75   334,385   139 (275,630)
Ending Balance (in shares) at Sep. 30, 2024     75,454,375          
Beginning Balance at Dec. 31, 2023 82,547   $ 68   321,642   (29) (239,134)
Beginning Balance (in shares) at Dec. 31, 2023     68,283,699          
Ending Balance at Dec. 31, 2024 99,644   $ 94   386,534   61 (287,045)
Ending Balance (in shares) at Dec. 31, 2024     93,602,631          
Beginning Balance at Jun. 30, 2024 66,174   $ 73   328,573   (84) (262,388)
Beginning Balance (in shares) at Jun. 30, 2024     72,591,917          
Stock-based compensation 822       822      
Issuance of common stock from exercise of stock options 162       162      
Issuance of common stock from exercise of stock options (in shares)     113,736          
Issuance of common stock, net of commissions and allocated fees, less issuance costs   $ 4,830   $ 1   $ 4,829    
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)       1,611,803        
Issuance of common stock from pre-funded warrant exercise     $ 1   (1)      
Issuance of common stock from pre-funded warrant exercise (in shares)     1,136,919          
Unrealized gains (losses) on available-for-sale marketable securities 223           223  
Net loss (13,242)             (13,242)
Ending Balance at Sep. 30, 2024 58,969   $ 75   334,385   139 (275,630)
Ending Balance (in shares) at Sep. 30, 2024     75,454,375          
Beginning Balance at Dec. 31, 2024 99,644   $ 94   386,534   61 (287,045)
Beginning Balance (in shares) at Dec. 31, 2024     93,602,631          
Stock-based compensation 3,835       3,835      
Issuance of common stock from exercise of stock options $ 1,854       1,854      
Issuance of common stock from exercise of stock options (in shares) 772,857   772,857          
Issuance of common stock, net of commissions and allocated fees, less issuance costs $ 107,388   $ 20   107,368      
Issuance of common stock, net of commissions and allocated fees, less issuance costs (in shares)     20,010,000          
Issuance of common stock from Employee Stock Purchase Plan 59       59      
Issuance of common stock from Employee Stock Purchase Plan (in shares)     15,898          
Issuance of common stock from warrant exercise 10,757   $ 8   10,749      
Issuance of common stock from warrant exercise (in shares)     7,851,852          
Issuance of common stock from pre-funded warrant exercise     $ 6   (6)      
Issuance of common stock from pre-funded warrant exercise (in shares)     5,961,875          
Unrealized gains (losses) on available-for-sale marketable securities (31)           (31)  
Proceeds from disgorgement of beneficial owner's short-swing profits 725       725      
Net loss (34,443)             (34,443)
Ending Balance at Sep. 30, 2025 189,788   $ 128   511,118   30 (321,488)
Ending Balance (in shares) at Sep. 30, 2025     128,215,113          
Beginning Balance at Jun. 30, 2025 198,493   $ 122   508,033   24 (309,686)
Beginning Balance (in shares) at Jun. 30, 2025     121,775,753          
Stock-based compensation 1,243       1,243      
Issuance of common stock from exercise of stock options 1,123       1,123      
Issuance of common stock from exercise of stock options (in shares)     477,485          
Issuance of common stock from pre-funded warrant exercise     $ 6   (6)      
Issuance of common stock from pre-funded warrant exercise (in shares)     5,961,875          
Unrealized gains (losses) on available-for-sale marketable securities 6           6  
Proceeds from disgorgement of beneficial owner's short-swing profits 725       725      
Net loss (11,802)             (11,802)
Ending Balance at Sep. 30, 2025 $ 189,788   $ 128   $ 511,118   $ 30 $ (321,488)
Ending Balance (in shares) at Sep. 30, 2025     128,215,113